The results showed that the expression level of ARHGAP11A was closely related to tumor differentiation (p < 0.05, Figure 1(h) and Table 1) but was not significantly correlated with age, sex, clinical stage, TNM stage, or other clinicopathological characteristics of the patients (p > 0.05; Table 2). This evidence concerns the gene ARHGAP11A and neoplasm.